Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Nagata

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Journal of Gastroenterology|February 1, 2003
Association of hereditary spherocytosis with familial adenomatous polyposis in a pedigree: a new syndrome or coincidence?Keiji Hirata, Kentaro Matsumoto, Kiyoshi Gondo, et al.
Anticancer Research|November 2, 2004
Relationships between local and systemic expression of interleukin-12 and plasma levels of vascular endothelial growth factor in patients with gastric cancerYoshifumi Nakayama, Yuzuru Inoue, Nobuo Nagashima, et al.
Anticancer Research|August 17, 2005
Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancerYuzuru Inoue, Yoshifumi Nakayama, Noritaka Minagawa, et al.
Anticancer Research|November 11, 2006
Correlation between the urinary dihydrouracil-uracil ratio and the 5-FU plasma concentration in patients treated with oral 5-FU analogsYoshifumi Nakayama, Kentaro Matsumoto, Yuzuru Inoue, et al.
Anticancer Research|August 15, 2002
Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancerYoshifumi Nakayama, Tatsuhiko Sako, Kazunori Shibao, et al.
Hepato-Gastroenterology|December 24, 2008
Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancerNaoki Nagata, Masayuki Kimura, Naoki Hirabayashi, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2021
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)Keiichiro Ishibashi, Toru Aoyama, Masahito Kotaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2004
[A case of advanced gastric cancer effectively treated by combined chemotherapy of paclitaxel (TXL) and CDDP]Naoki Nagata, Yuzuru Inoue, Masayuki Fukushima, et al.
Cancer|April 5, 2002
Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinomaKazunori Shibao, Hiroto Izumi, Yoshifumi Nakayama, et al.
Cancer Science|April 24, 2003
Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinomaKoji Onitsuka, Kazunori Shibao, Yoshifumi Nakayama, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of Gastroenterology|February 1, 2003
Association of hereditary spherocytosis with familial adenomatous polyposis in a pedigree: a new syndrome or coincidence?Keiji Hirata, Kentaro Matsumoto, Kiyoshi Gondo, et al.
Anticancer Research|November 2, 2004
Relationships between local and systemic expression of interleukin-12 and plasma levels of vascular endothelial growth factor in patients with gastric cancerYoshifumi Nakayama, Yuzuru Inoue, Nobuo Nagashima, et al.
Anticancer Research|August 17, 2005
Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancerYuzuru Inoue, Yoshifumi Nakayama, Noritaka Minagawa, et al.
Anticancer Research|November 11, 2006
Correlation between the urinary dihydrouracil-uracil ratio and the 5-FU plasma concentration in patients treated with oral 5-FU analogsYoshifumi Nakayama, Kentaro Matsumoto, Yuzuru Inoue, et al.
Anticancer Research|August 15, 2002
Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancerYoshifumi Nakayama, Tatsuhiko Sako, Kazunori Shibao, et al.
Hepato-Gastroenterology|December 24, 2008
Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancerNaoki Nagata, Masayuki Kimura, Naoki Hirabayashi, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2021
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)Keiichiro Ishibashi, Toru Aoyama, Masahito Kotaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2004
[A case of advanced gastric cancer effectively treated by combined chemotherapy of paclitaxel (TXL) and CDDP]Naoki Nagata, Yuzuru Inoue, Masayuki Fukushima, et al.
Cancer|April 5, 2002
Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinomaKazunori Shibao, Hiroto Izumi, Yoshifumi Nakayama, et al.
Cancer Science|April 24, 2003
Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinomaKoji Onitsuka, Kazunori Shibao, Yoshifumi Nakayama, et al.
Pageof 9